Drug Trial Radar · NCT05575700
Safety of Ibuprofen After Major Orthopaedic Surgeries
Last checked: Nov 19, 2026Latest source record: Dec 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,904
Actual
Start
Apr 17, 2023
Primary completion
Aug 19, 2025
Study completion Aug 19, 2025
Sponsor
- Lead sponsor
- Naestved HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 12, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety of an eight-day treatment with ibuprofen after primary hip and knee arthroplasties.
Conditions
- Pain, Acute
- Hip Arthropathy
- Knee Arthropathy
- Safety Issues
- Analgesia
- Analgesic Adverse Reaction
- Postoperative Pain
- Postoperative Complications
Interventions
IbuprofenDrug
400 mg tablet three times daily
PlaceboDrug
tablet three times daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- A composite outcome of either death, acute myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, renal failure, major bleeding, re-operation, gastrointestinal ulcer, or readmission within 90 days postoperatively.Time frame: Postoperative day 0 to 90.
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Private Hospital Gildhøj
Brøndby, Denmark
Bispebjerg Hospital
Copenhagen NV, Denmark
Aalborg University Hospital
Farsø, Denmark
Gentofte Hospital
Hellerup, Denmark
Nordsjællands Hospital Hillerød
Hillerød, Denmark
Zealand University Hospital
Køge, Denmark
Næstved Hospital
Næstved, Denmark
Odense University Hospital
Odense, Denmark
Silkeborg Regional Hospital
Silkeborg, Denmark
Svendborg Hospital
Svendborg, Denmark
Vejle Sygehus
Vejle, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.